Jared Gollob insider trades: Kymera Therapeutics (KYMR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jared reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | KYMR | ↓ Sell | 10,508 | $87.24 | $917K | Direct | Mar 4, 2026 (0d) |
| Dec 8, 2025 | KYMR | ↓ Sell | 49,307 | $88.67 | $4.4M | Direct | Dec 8, 2025 (0d) |
| Oct 15, 2025 | KYMR | ↓ Sell | 59,576 | $61.42 | $3.7M | Direct | Oct 15, 2025 (0d) |
| Oct 13, 2025 | KYMR | ↓ Sell | 3,114 | $60.00 | $187K | Direct | Oct 14, 2025 (1d) |
| Mar 3, 2025 | KYMR | ↓ Sell | 5,740 | $30.45 | $175K | Direct | Mar 3, 2025 (0d) |
| Jul 16, 2024 | KYMR | ↓ Sell | 39,600 | $45.53 | $1.8M | Direct | Jul 16, 2024 (0d) |
| Mar 4, 2024 | KYMR | ↓ Sell | 3,344 | $41.86 | $140K | Direct | Mar 4, 2024 (0d) |
| Feb 27, 2024 | KYMR | ↓ Sell | 400 | $45.00 | $18K | Direct | Feb 29, 2024 (2d) |
| Feb 9, 2024 | KYMR | ↓ Sell | 46,137 | $35.50 | $1.6M | Direct | Feb 9, 2024 (0d) |
| Mar 2, 2023 | KYMR | ↓ Sell | 1,298 | $31.00 | $40K | Direct | Mar 3, 2023 (1d) |
| Nov 2, 2021 | KYMR | ↓ Sell | 57,493 | $62.16 | $3.6M | Direct | Nov 2, 2021 (0d) |
| Mar 15, 2021 | KYMR | ↓ Sell | 15,000 | $60.13 | $902K | Direct | Mar 15, 2021 (0d) |
| Feb 24, 2021 | KYMR | ↓ Sell | 37,064 | $50.68 | $1.9M | Direct | Feb 24, 2021 (0d) |
| Feb 19, 2021 | KYMR | ↓ Sell | 22,936 | $56.42 | $1.3M | Direct | Feb 19, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KYMR insiders
Open-market trades in the last 12 months
About Jared Gollob's insider trades
Jared Gollob is Chief Medical Officer at Kymera Therapeutics (KYMR). Since Feb 19, 2021, Jared has reported no open-market purchases and 14 sales worth $20.6M on SEC Form 4. In the last 12 months: 2 sales ($5.3M).
Their filings also include option exercises (9 filings), grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KYMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.